Topic: Lung Cancer
CHICAGO (Reuters) - The common diabetes drug metformin may hold promise as a way to keep smokers from developing lung cancer, U.S. researchers said on Wednesday. They said metformin prevented lung tumor growth in mice exposed to a cancer-causing agent found in ...
ZURICH (Reuters) - Roche's top-selling Avastin helps patients with the most common form of lung cancer live longer than any other treatment, the Swiss drugmaker said on Friday, giving the drug a boost after a slew of setbacks. A late-stage trial showed ...
Bayer and Onyx Pharmaceuticals say Nexavar does not meet study goal as a lung cancer treatmentBayer HealthCare and Onyx Pharmaceuticals Inc. said Monday their cancer treatment Nexavar failed to boost survival in a clinical study involving patients with a certain type of ...
Abraxis BioScience says data shows Abraxane works better than Taxol in lung cancer studyAbraxis BioScience said data from a late-stage study in lung cancer patients showed its drug Abraxane worked better than Taxol when given in combination with a chemotherapy drug. Abraxane ...
A new experimental drug helps shrink tumors in lung cancer patients with a specific form of genetic alteration, according to results from a clinical trial unveiled Saturday. The Pfizer Inc. drug crizotinib shrank tumors in patients with advanced non-small cell lung cancer ...
Pfizer drug shows big promise in early testing for lung cancer patients with a certain geneDoctors are reporting unusually high success rates from early tests of an experimental lung cancer drug. The drug, called crizotinib, (crih-ZAH-tin-ib), is made by Pfizer Inc. It ...
NEW YORK (Reuters) - An experimental drug being developed by Pfizer Inc that targets a specific gene mutation demonstrated impressive anti-tumor activity in patients with advanced non-small cell lung cancer (NSCLC), according to data from a small study presented on Saturday. More ...
WASHINGTON (Reuters) - A drug approved to treat a range of conditions may also work to prevent lung cancer in people who have given up smoking, U.S. researchers reported on Tuesday. The drug, called iloprost, is approved in inhaled forms to treat ...
NEW YORK (Reuters Health) - Almost twice as many Swedes as Britons survive the first five years after a lung cancer diagnosis, a new report reveals. By examining nationwide cancer registries and death certificates in three countries, doctors found that survival rates ...
WASHINGTON (Reuters) - Researchers said they helped advanced lung cancer patients fare better by matching their tumors to targeted drugs, in what they said is the first significant trial to show it is possible to choose the best drug for an individual ...
